Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by OptimizeRx Corporation
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
March 11, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
March 10, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
February 27, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
December 23, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
November 18, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Third Quarter 2024 Financial Results
November 13, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
October 31, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
September 10, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
September 09, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Second Quarter 2024 Financial Results
August 08, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
July 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
July 23, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
July 15, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
June 20, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports First Quarter 2024 Financial Results
May 14, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
May 06, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
April 26, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
April 16, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 11, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
March 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 11, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
March 04, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
WMT
OptimizeRx to Participate in Upcoming Investor Conferences
February 21, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
January 25, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
AWH
OPRX
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
January 09, 2024
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
December 18, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Reports Third Quarter 2023 Financial Results
November 06, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
October 25, 2023
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.